(Q45217126)

10 December 2017

title

Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure (English)

1 reference

10 December 2017

1 reference

Lowe NJ

1

1 reference

10 December 2017

Wieder JM

2

1 reference

10 December 2017

Rosenbach A

3

1 reference

10 December 2017

Johnson K

4

1 reference

10 December 2017

Kunkel R

5

1 reference

10 December 2017

Bainbridge C

6

1 reference

10 December 2017

Bourget T

7

1 reference

10 December 2017

Dimov I

8

1 reference

10 December 2017

Simpson K

9

1 reference

10 December 2017

Glass E

10

1 reference

10 December 2017

Grabie MT

11

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

Journal of the American Academy of Dermatology

10 December 2017

published in

1 reference

10 December 2017

volume

35

1 reference

10 December 2017

issue

5 Pt 1

1 reference

10 December 2017

page(s)

710-719

1 reference

Mechanism of action and rationale for cyclosporin A in psoriasis

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Short-term use of cyclosporin A in severe psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Efficacy of low-dose cyclosporin A in psoriasis: results of dose-finding studies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Low-dose cyclosporin A in severe psoriasis. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Use of cyclosporin in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Oral cyclosporin A in the treatment of psoriasis: an overview of studies performed in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Four years of experience with cyclosporin A for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Renal function and blood pressure in psoriatic patients treated with cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Chronic nephrotoxicity in psoriatic patients treated with low-dose cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Renal function and biopsy findings after 5 years' treatment with low-dose cyclosporin for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Morphologic renal changes during cyclosporine treatment of psoriasis. Studies on pretreatment and posttreatment kidney biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Cyclosporine therapy for psoriasis: serum creatinine measurements are an unreliable predictor of decreased renal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

Systemic treatment of severe psoriasis--the role of cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990726-4

7 January 2021

10.1016/S0190-9622(96)90726-4

Identifiers

DOI

1 reference

10 December 2017

1 reference